Handelsbanken Fonder’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.5M | Sell |
34,650
-3,300
| -9% | -$142K | 0.01% | 772 |
|
|
2025
Q1 | $1.31M | Hold |
37,950
| – | – | 0.01% | 828 |
|
|
2024
Q4 | $1.04M | Buy |
37,950
+5,400
| +17% | +$148K | ﹤0.01% | 949 |
|
|
2024
Q3 | $829K | Buy |
32,550
+4,900
| +18% | +$125K | ﹤0.01% | 1016 |
|
|
2024
Q2 | $700K | Buy |
27,650
+1,300
| +5% | +$32.9K | ﹤0.01% | 1001 |
|
|
2024
Q1 | $815K | Hold |
26,350
| – | – | ﹤0.01% | 931 |
|
|
2023
Q4 | $1.06M | Buy |
26,350
+1,600
| +6% | +$64.6K | 0.01% | 769 |
|
|
2023
Q3 | $653K | Buy |
24,750
+1,000
| +4% | +$26.4K | ﹤0.01% | 925 |
|
|
2023
Q2 | $408K | Hold |
23,750
| – | – | ﹤0.01% | 1177 |
|
|
2023
Q1 | $394K | Hold |
23,750
| – | – | ﹤0.01% | 1128 |
|
|
2022
Q4 | $181K | Buy |
23,750
+3,800
| +19% | +$29K | ﹤0.01% | 1455 |
|
|
2022
Q3 | $198K | Hold |
19,950
| – | – | ﹤0.01% | 1436 |
|
|
2022
Q2 | $181K | Hold |
19,950
| – | – | ﹤0.01% | 1512 |
|
|
2022
Q1 | $202K | Hold |
19,950
| – | – | ﹤0.01% | 1632 |
|
|
2021
Q4 | $333K | Sell |
19,950
-4,800
| -19% | -$80.1K | ﹤0.01% | 1578 |
|
|
2021
Q3 | $1.16M | Buy |
24,750
+3,800
| +18% | +$178K | 0.01% | 828 |
|
|
2021
Q2 | $1.28M | Buy |
20,950
+1,800
| +9% | +$110K | 0.01% | 795 |
|
|
2021
Q1 | $1.18M | Buy |
19,150
+5,550
| +41% | +$342K | 0.01% | 768 |
|
|
2020
Q4 | $967K | Hold |
13,600
| – | – | 0.01% | 842 |
|
|
2020
Q3 | $510K | Hold |
13,600
| – | – | ﹤0.01% | 980 |
|
|
2020
Q2 | $443K | Buy |
+13,600
| New | +$443K | ﹤0.01% | 1016 |
|